A Blockbuster Year Ahead For Health, Life Sciences Litigation
By Jeff Overley (January 3, 2022, 12:03 PM EST) -- Health care and life sciences litigation is already red hot as 2022 begins and appears all but certain to intensify throughout the year as the clock ticks on time-sensitive lawsuits, the U.S. Supreme Court nears the end of its current term and opioid cases generate more trials and fresh drama. Here, Law360 explores five key litigation areas to watch.
Make-Or-Break Rulings Imminent For No Surprises Act
National and state lobbying groups for health care providers are entering 2022 having just commenced litigation challenging the mechanics of a high-profile arbitration system that debuted on New Year's Day, about one year after its...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!